Zymfentra (infliximab-dyyb subcutaneous) - Celltrion
Tremfya (guselkumab) - J&J
Stelara (ustekinumab) - J&J
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Rinvoq (upadacitinib) - AbbVie
Entyvio (vedolizumab) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/42796099
 
Belén Botella; Esteban Fuentes-Valenzuela; Francisco Javier Tarrasó; Isabel Vera; Marisa Iborra; Pilar Nos
 
Sep 27, 2026
 
Prev Next